ADVERTISEMENT
site_logo
  • Campus
  • Happening
  • Opinion
  • People
  • News
  • #BeInspired
  • Careers
  • 40 under 40
  • Exams
  • What The FAQ
  • Videos
    • Straight Up
    • Odisha Literary Festival 2020
    • Campus Convo
    • Careers After Corona
    • Express Expressions
    • Q&A With Prabhu Chawla
    • ThinkEdu Awards 2020
  • Web Stories
  • edex_worksEDEXWORKS
ADVERTISEMENT
COVID-19

Published: 02nd September 2021     

Study finds that rogue antibodies drive severity, death in COVID-19 patients

The rogue antibodies are known as autoantibodies, and are also present in a small proportion of healthy, uninfected individuals and their prevalence increases with age

Edex Live
Edex Live
f_icon t_icon i_icon l_icon koo_icon whatsapp_icon email_icon Google News

Share Via Email

COVID-_pixabay

Representative Image | Pic: Pixabay

Antibodies that turn against the body's own immune systems are the reason for severe illness and death among one-fifth of COVID-19 patients, according to a large international study.

These rogue antibodies are known as autoantibodies, and are also present in a small proportion of healthy, uninfected individuals and their prevalence increases with age, which may help to explain why elderly people are at higher risk of severe COVID-19,  a report said.

The findings, published in the journal Science Immunology, showed that around 10 per cent of people with severe COVID-19 had autoantibodies that attack and block type interferons protein molecules in the blood that have a critical role in fighting off viral infections The team at the Rockefeller University in New York City, first studied 3,595 patients from 38 countries with critical COVID-19, meaning that the individuals were ill enough to be admitted to an intensive-care unit. Overall, 13.6 per cent of these patients possessed autoantibodies, with the proportion ranging from 9.6 per cent of those below the age of 40, up to 21 per cent of those over 80. Autoantibodies were also present in 18 per cent of people who had died of the disease.

The researchers suspected that these devious antibodies were a cause, rather than a consequence, of critical COVID-19. The team also found that individuals with genetic mutations that disrupt the activity of type 1 interferons are at higher risk of life-threatening disease. Further, the researchers extended the probe for autoantibodies in blood samples taken from almost 35,000 healthy people before the pandemic. They found that 0.18 per cent of those between 18 and 69 had existing autoantibodies against type 1 interferon, and that this proportion increased with age: autoantibodies were present in around 1.1 per cent of 70 to 79-year-olds, and 3.4 per cent of those over the age of 80. "There is a massive increase in prevalence" with age, said immunologist Jean-Laurent Casanova at the varsity. "This largely explains the high risk of severe COVID-19 in people in the elderly population," he added.

telegram
TAGS
COVID-19 antibody immune system

O
P
E
N

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
telegram
ADVERTISEMENT
Write to us!

If you have campus news, views, works of art, photos or just want to reach out to us, just drop us a line.

newsletter_icon
Mailbox
edexlive@gmail.com
fb_icon
Facebook
twitter_icon
Twitter
insta_icon
Instagram
ADVERTISEMENT
Facebook
ADVERTISEMENT
Tweets by Xpress_edex
ADVERTISEMENT
ADVERTISEMENT

FOLLOW US

The New Indian Express | The Morning Standard | Dinamani | Kannada Prabha | Samakalika Malayalam | Cinema Express | Indulgexpress | Events Xpress

Contact Us | About Us | Privacy Policy | Terms of Use | Advertise With Us

Home | Live Now | Live Story | Campus Trip | Coach Calling | Live Take

Copyright - edexlive.com 2023. All rights reserved. Website Designed, Developed & Maintained by Express Network Private Ltd.